| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,242 | 13,865 | 17,845 | 16,735 | | Cost of Revenue | 7,381 | 12,761 | 14,224 | (4,017) | | | Gross Profit | 1,861 | 1,104 | 3,621 | 20,752 | | | Operating Expenses | | Research Development | 7 | 16 | 31 | 3 | | Selling General and Administrative | 12,101 | 6,037 | 7,953 | 24,363 | | Non Recurring |
-
|
-
|
-
| 18,615 | | Others | 2,371 | 2,418 | 2,633 | 2,567 | | | | Total Operating Expenses |
-
|
-
|
-
| 45,548 | | | | Operating Income or Loss | (12,618) | (7,367) | (6,996) | (24,796) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26 | 134 | 711 | (122) | | Earnings Before Interest And Taxes | (13,602) | (6,223) | (6,285) | (24,918) | | Interest Expense | 2,257 | 1,526 | 569 | 840 | | Income Before Tax | (15,859) | (7,749) | (6,854) | (25,758) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 679 | 524 | 486 |
-
| | | | Net Income From Continuing Ops | (14,170) | (8,235) | (6,368) | (25,758) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,170) | (8,235) | (6,368) | (25,758) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,170) | ($8,235) | ($6,368) | ($25,758) |
|
0.22% Nasdaq 
0.005 (1.56%) 
Income Statement
